Figure 1From: Recombinant and Plasma-Purified Human C1 Inhibitor for the Treatment of Hereditary AngioedemaTwo plasma-derived C1 inhibitor preparations, Cinryze (A) and Berinert (C), and a recombinant protein, Rhucin (B), provide faster symptom relief for acute HAE attacks than placebo. Reprinted with permission from (A) New England Journal of Medicine,[22], (B) Pharming Group NV, (C) Journal of Allergy and Clinical Immunology[23].Back to article page